Anesthetic management for a patient with transcatheter mitral valve implantation.

  title={Anesthetic management for a patient with transcatheter mitral valve implantation.},
  author={Kazım Karaaslan and Ufuk Topuz and Mehmet Akif Vatankulu and Erdoğan Ozturk},
  journal={Journal of cardiothoracic and vascular anesthesia},
  volume={28 1},
MITRAL VALVE REDO OPERATIONS due to failing bioprostheses are known to be associated with high rates of morbidity and mortality. Transcatheter mitral valve implantation (TMVI) procedures in high-risk patients with severe mitral regurgitation have become a promising treatment option. We report a new transcatheter technique as an alternative to redo operations in patients with degenerative mitral valve bioprosthesis. There are a limited number of studies on the use of this technique. The main… 
3 Citations

Figures from this paper

Anesthetic Considerations for the Transcatheter Management of Mitral Valve Disease.
The authors' institutional experience with anesthetic management for the TMVR and TMVRep procedures is described, including potential pitfalls and complications, concluding with a discussion of the role of transesophageal echocardiography in the care of this patient population.
Expert Consensus Systems of Care Proposal to Optimize Care for Patients With Valvular Heart Disease Review of the 2019 Document for the Cardiac Anesthesiologist.
This review focuses and expands on aspects discussed in Nishimura et al.'s Expert Consensus Systems of Care Document that are relevant to the cardiac anesthesiologist in the periprocedural setting.


Anesthetic management of transcatheter aortic valve implantation with transaxillary approach.
Transaxillary TAVI is feasible in high-risk patients with aortic stenosis and peripheral vasculopathy, Nevertheless, severe procedural complications are possible, and anesthesiologists should be prepared to assist in the management of these conditions.
Anesthetic management of percutaneous aortic valve implantation: focus on challenges encountered and proposed solutions.
Transcatheter aortic valve implantation is possible in selected high-risk patients and anesthesiologists must be aware of current technology in order to have an active role in patient selection, to develop monitoring and standards of care in the cardiac catheterization laboratory, and to plan postoperative management.
Noninvasive ventilation for awake percutaneous aortic valve implantation in high-risk respiratory patients: a case series.
Noninvasive positive-pressure ventilation (NIV) is a technique for delivering mechanical ventilation that increasingly is being used for acute and chronic conditions and may avoid most of the complications of invasive mechanical ventilation while ensuring a similar degree of efficacy at the same time.
Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis
Benefit of TAVI with the CoreValve Revalving System is maintained over time up to 1 year, with acceptable mortality rates at various time points, although procedural complications are strongly associated with early mortality at 30 days.
Awake transapical aortic valve implantation using thoracic epidural anesthesia.
Transcatheter aortic valve insertion: anaesthetic implications of emerging new technology.
The results of this study show a worthwhile improvement to already acceptable levels of analgesia, sustained over a reasonable period of time, and are no mean achievement for a combination of two established and inexpensive drugs used in doses that have an excellent safety record.